SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-16-006976
Filing Date
2016-07-20
Accepted
2016-07-20 14:00:20
Documents
34
Period of Report
2016-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sibannac_10q-053116.htm 10-Q 142926
2 CERTIFICATION sibannac_ex3101.htm EX-31.1 7487
3 CERTIFICATION sibannac_ex3102.htm EX-31.2 7662
4 CERTIFICATION sibannac_ex3201.htm EX-32.1 3776
5 CERTIFICATION sibannac_ex3202.htm EX-32.2 3660
  Complete submission text file 0001019687-16-006976.txt   1033719

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE none-20160531.xml EX-101.INS 104232
7 XBRL SCHEMA FILE none-20160531.xsd EX-101.SCH 12367
8 XBRL CALCULATION FILE none-20160531_cal.xml EX-101.CAL 27785
9 XBRL DEFINITION FILE none-20160531_def.xml EX-101.DEF 26918
10 XBRL LABEL FILE none-20160531_lab.xml EX-101.LAB 111508
11 XBRL PRESENTATION FILE none-20160531_pre.xml EX-101.PRE 80994
Mailing Address 1313 E. OSBORN PHOENIX AZ 85014
Business Address 1313 E. OSBORN PHOENIX AZ 85014 480-420-3171
Sibannac, Inc. (Filer) CIK: 0001313938 (see all company filings)

IRS No.: 330903494 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-55578 | Film No.: 161775131
SIC: 2834 Pharmaceutical Preparations